Radiogenomic as a new noninvasive approach for assessment of Ki67 expression in breast cancer from MRI images

Radiogenomic as a new noninvasive approach for assessment of Ki67 expression in breast cancer from MRI images


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: داود خضرلو , یونس سلیمانی کیچی قلعه سی

عنوان کنگره / همایش: دهمین کنگره بین الملی سرطان پستان , Iran (Islamic Republic) , تهران , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله داود خضرلو
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پیراپزشکی
کد مقاله 72064
عنوان فارسی مقاله Radiogenomic as a new noninvasive approach for assessment of Ki67 expression in breast cancer from MRI images
عنوان لاتین مقاله Radiogenomic as a new noninvasive approach for assessment of Ki67 expression in breast cancer from MRI images
نوع ارائه پوستر
عنوان کنگره / همایش دهمین کنگره بین الملی سرطان پستان
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1398
سال انتشار/ارائه میلادی 2019
تاریخ شمسی شروع و خاتمه کنگره/همایش 1398/08/01 الی 1398/08/03
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی 1. Deportment of Radiology, Paramedical Faculty , Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
داود خضرلواول
یونس سلیمانی کیچی قلعه سیدوم

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهIntroduction: Extraction of clinical and genomic information through mathematical and statistical features from medical images is called radiomics and radiogenomics respectively. Ki67 labeling biomarker is a predictive and prognostic index of breast cancer. Biomarkers are determined by immunohistology tests and biopsy, which are aggressive and have systematic and random errors. Also, biomarkers are heterogeneously distributed and their pattern change during treatment. In breast cancer, radiogenomics is a type of non-invasive histopathologic sampling extracted from MRI images and applied to the following scopes: differentiation of benign masses from malignant, pathologic staging, molecular and genomic subtyping and prognosis in terms of invasiveness .The purpose of this study was to investigate whether MRI-Radiogenomic can predict Ki 67 expression. Material and methods: The keywords of 'Breast Cancer', 'Radiomics', 'Radiogenomics' and “MRI” were entered in the scientific databases of Google scholar, Scopus, PubMed, and Elsevier. About 10 fully relevant articles were extracted and reviewed. Then the correlation between MRI-based radiogenomics and Ki67 expression were obtained and assessed. Results: All papers indicated that T2-weighted MRI and T2-weighted DCE-MRI images were suitable for Ki67 biomarker analysis. Among morphological, gray scale and textural-based features, the texture features had highest correlation with Ki67. So that tumors with high Ki67 level shows high texture features. The DCE-MRI has a high sensitivity but low specificity for Ki67 detection. Also, it is a time-consuming scan and features depends on time patterns. Nevertheless T2-weighted scan is fast. Studies showed that Area under ROC curve (AUC) was about 0.7-0.78 in both T2-weighted DCE-MRI and T2-weighted MRI images. Conclusion: The results of our study showed that radiogenomics-based quantitative analysis of MR images, can significantly help to prediction of Ki67 expression.
کلمات کلیدیKey words: Breast Cancer', 'Radiomics', 'Radiogenomics' , “MRI”

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
2-breast MRI Radiomics.pdf1399/02/10781460دانلود
breast cancer-eBOOK.pdf1399/02/1015237890دانلود